Current Issue


New consensus statement on type 2 diabetes changes recommended drugs

The recommendations from the American Diabetes Association and the European Association for the Study of Diabetes encourage use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.

Treatment based on physiologic assessment may help prevent diabetes

In a retrospective observational study, patients with prediabetes were assigned to a risk category for diabetes based on presence and severity of insulin resistance, impaired beta-cell function, and hyperglycemia, then treated accordingly.

Hypoglycemia may be associated with myocardial damage

Among patients with coronary artery disease, severity and frequency of hypoglycemia were associated with increased levels of high-sensitivity cardiac troponin T, although the association was attenuated in adjusted analyses.

Integrated care model offers noninferior diabetes care to gold-standard specialist clinics

A study conducted in Australia found that general practitioners with specialization in diabetes care and subspecialist-led clinics reduced HbA1c levels by similar amounts in patients with complex type 2 diabetes.

MKSAP quiz: New rash with poorly controlled diabetes

This month's quiz asks readers to evaluate a 40-year-old man with an HbA1c of 12% and a new skin rash that appeared abruptly 10 days earlier.

Spotlight on artificial intelligence and diabetic retinopathy

One recent study reported on the development and validation of an artificial intelligence algorithm for detecting diabetic retinopathy, while another tested such technology in primary care.

FDA urges patients to use caution when injecting insulin with pen needles

The agency offered new recommendations after receiving reports of patients using standard pen needles to inject insulin without removing the inner needle cover.